• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cedars Sinai Launches COVID-19 Recovery Program

by Jasmine Pennic 01/26/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Cedars Sinai Launches COVID-19 Recovery Program

What You Should Know:

– Patients in the Cedars-Sinai COVID-19 Recovery Program receive a comprehensive in-person evaluation with an expert in infectious diseases or pulmonary medicine who can refer them to a network of specialists.


Cedars-Sinai, today announce the launch of the COVID-19 Recovery Program to meet the needs of a growing number of COVID-19 patients who experience lingering symptoms weeks and even months after physicians say they are virus-free.

COVID-19 Recovery Program Overview

Patients recovering from COVID-19 suffer from physical symptoms such as shortness of breath, continued loss of taste or smell, dizziness or headaches, to cognitive symptoms including fatigue, brain fog, or increased anxiety or depression. In response to this, Cedars-Sinai developed the COVID-19 Recovery Program to connect patients who are experiencing persistent symptoms after COVID-19 to a network of specialists in order to provide the most comprehensive and best care available based on the latest developing understanding of the disease. In addition, patients can also opt to participate in clinical trials and contribute to a deeper understanding of long-term effects of COVID-19. 

To amplify its efforts, the COVID-19 Recovery Program works closely with two other Cedars-Sinai efforts:

– The Smidt Heart Institute’s Post-COVID-19 Cardiology Program, which enrolls patients who have been diagnosed with a heart issue associated with post-COVID-19 recovery.

– The Cedars-Sinai Department of Medicine’s Post-ICU Clinic, which focuses primarily on respiratory and neurological problems that develop in some intensive care unit patients after they are discharged.

“Given the sheer number of people worldwide who have had COVID-19–more than 90 million–if even 1% experience symptoms beyond three months, that is a huge number of patients who need help,” said program co-director Catherine Le, MD, an infectious disease specialist with Cedars-Sinai Medical Group. “For some patients, we are the first physicians they’ve seen in person since their diagnosis. Even if we don’t have all the answers right now, it puts many of our patients at ease to speak with an expert and get a complete evaluation.”

Eligibility Requirements

To be eligible for treatment in the program, patients must:

– Be referred by a physician.

– Have had COVID-19, confirmed by a positive test result.

– Be experiencing persistent symptoms.


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cedars-Sinai, Clinical Trials, Coronavirus (COVID-19), Depression, Heart, MD, medical group, physicians

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |